Motor Imagery in Chronic Obstructive Pulmonary Disease

NCT ID: NCT07171957

Last Updated: 2025-09-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

188 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-08-01

Study Completion Date

2026-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to compare the motor imagery ability of individuals with Chronic Obstructive Pulmonary Disease (COPD) with those without COPD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will begin after receiving approval from the KSBU Non-Interventional Ethics Committee for its compliance. Before data collection begins, each participant who agrees to the study will be informed about the study, and will be asked to sign a voluntary consent form. After obtaining demographic and disease-specific information, participants will be divided into two groups: COPD and non-COPD individuals, and their cognitive skills, dominant hand preference, and motor imagery abilities will be assessed. The cognitive functions of all participants will be assessed using the Standardized Mini Mental State Examination. Participants will be included in the study if they score ≥24. The dominant hand preference of the participants will be determined using the Edinburgh Hand Preference Questionnaire and recorded on the assessment form. In the tests and surveys to be conducted, the dominant hand will be determined based on the results of this questionnaire, and the results of tests performed with the dominant side will be recorded. The GOLD ABE Assessment Tool will be used to assess COPD patients. As part of the GOLD ABE Assessment Tool, patients' pulmonary function test results, COPD Assessment Test (CAT) results, Modified Health Research Council Dyspnoea Scale (mMRC) results, exacerbation history, and hospitalization history will be recorded. Oxygen saturation values of COPD patients will be recorded. Routine measurement results for oxygen saturation and pulmonary function test values of individuals with COPD will be recorded. Participants' motor imagery skills will be assessed using the Kinesthetic and Visual Motor Imagery Questionnaire-20 (KVIQ-20). The Nine-Hole Peg Test will be used to assess the temporal correspondence between participants' actual and imagined movement (mental chronometry). Temporal correspondence between actual and imagined movement will be calculated using the formula. Participants' mental rotation abilities will be assessed using the hand laterality test (hand identification test), one of the mental rotation subcomponents, using the Recognise Hand mobile application. Data obtained from individuals with COPD and individuals without COPD will be recorded. Based on the data obtained, the motor imagery abilities of the two groups will be compared using appropriate statistical methods. The correlation between the disease-specific knowledge of individuals in the COPD group and their motor imagery abilities will be calculated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease (COPD) Mental Imagery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

COPD group

Study group

No interventions assigned to this group

Control Group

Healthy group

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being between 40-70 years of age
* Being diagnosed with COPD
* Having 24 points or more on the Mini Mental State Examination
* Not having a history of acute exacerbation and/or hospitalization in the last month and being clinically stable

Exclusion Criteria

* Being between 40-70 years old
* Having a score of 24 or above on the Mini Mental State Examination
* Not having any pulmonary, cardiac, orthopedic or neurological disease
Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kutahya Health Sciences University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lütfiye AKKURT, MSc

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lütfiye AKKURT, Asst.Prof.

Role: STUDY_DIRECTOR

Kütahya Health Sciences University

İlknur KAYA, Asst.Prof.

Role: STUDY_CHAIR

Kütahya Health Sciences University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kütahya Health Sciences University

Kütahya, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025/07-09

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.